Valuation: RaySearch Laboratories AB

Market Cap 6.82B 694M 622M 572M 518M 968M 65.89B 986M 2.74B 34.66B 2.6B 2.55B 109B P/E 2026 *
26x
P/E 2027 * 20.9x
Enterprise Value 6.98B 711M 637M 586M 531M 992M 67.5B 1.01B 2.8B 35.51B 2.67B 2.61B 112B EV / Sales 2026 *
5.05x
EV / Sales 2027 * 4.24x
Free-Float
80.09%
Yield 2026 *
1.97%
Yield 2027 * 2.22%
1 day-1.36%
1 week+3.63%
Current month-1.53%
1 month+10.33%
3 months+14.11%
6 months+8.95%
Current year-12.41%
1 week 191.1
Extreme 191.1
203.8
1 month 180.6
Extreme 180.6
203.8
Current year 153.1
Extreme 153.1
238.4
1 year 153.1
Extreme 153.1
264.5
3 years 84.1
Extreme 84.1
373.5
5 years 40
Extreme 40
373.5
10 years 40
Extreme 40
373.5
Manager TitleAgeSince
Chief Executive Officer 57 1999-12-31
Director of Finance/CFO 48 2025-01-26
Chief Tech/Sci/R&D Officer 53 2015-08-27
Director TitleAgeSince
Director/Board Member 57 1999-12-31
Chairman 81 2016-11-17
Chairman 87 2022-09-29
Date Insider Type Main position Quantity % Market Cap. Importance
8/18/26 Sell

Chief Technology Officer

-3,203 0.0104%
8/17/26 Sell

Chief Technology Officer

-2,297 0.0075%
6/11/26 Buy

General Counsel

462 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-1.48%+3.63%-10.85%+126.93% 694M
-1.72%+3.44%+22.84%+58.01% 258B
-2.00%+0.75%+7.82%+22.23% 163B
-3.73%-4.48%-19.14%+59.73% 150B
-1.66%-8.12%-58.32%-18.74% 60.84B
+0.96%+2.60%-11.12%-8.44% 53.31B
-2.57%+3.30%+11.59%+44.15% 53.03B
+0.84%-3.12%+7.47%+67.31% 50.67B
-3.47%+1.04%+19.48%+70.01% 49.3B
-3.61%+1.99%+32.36%+92.13% 45.46B
Average -1.84%+0.29%+0.21%+51.33% 88.47B
Weighted average by Cap. -2.05%+0.16%+4.05%+44.59%

Financials

2026 *2027 *
Net sales 1.38B 141M 126M 116M 105M 196M 13.36B 200M 555M 7.03B 528M 517M 22.17B 1.61B 164M 147M 135M 123M 229M 15.6B 234M 648M 8.21B 617M 604M 25.89B
Net income 266M 27.03M 24.2M 22.26M 20.17M 37.71M 2.57B 38.41M 107M 1.35B 101M 99.27M 4.26B 328M 33.39M 29.9M 27.5M 24.92M 46.58M 3.17B 47.46M 132M 1.67B 125M 123M 5.26B
Net Debt 166M 16.9M 15.13M 13.92M 12.61M 23.58M 1.6B 24.02M 66.64M 844M 63.41M 62.07M 2.66B 33M 3.36M 3.01M 2.77M 2.51M 4.69M 319M 4.77M 13.25M 168M 12.61M 12.34M 529M
Projected Income Statement - Annual - RaySearch Laboratories AB
Logo RaySearch Laboratories AB
RaySearch Laboratories AB (publ) is a Sweden-based medical technology company that develops software for radiation therapy of cancer. It markets and sells its products mainly in the United States and in Europe through license agreements with medical technology companies and scientific institutions. Additionally, its solutions include software for optimizing Intensity Modulated Radiation Therapy (IMRT) plans for photons, adaptive technology for IMRT treatments and software for proton treatments. The Company’s commercial partners are Philips, Nucletron and IBA Dosimetry, among others. In April 2014, it established a German subsidiary, RaySearch Germany GmbH.
Employees
464
Date Price Change Volume
26-11-02 SEK 199.70 -1.53% 39,904
26-10-30 SEK 202.80 +0.20% 51,949
26-10-29 SEK 202.40 +2.22% 91,185
26-10-28 SEK 198.00 +0.15% 101,252
26-10-27 SEK 197.70 +2.59% 87,278
Trader
Investor
Global
Quality
ESG MSCI
CCC
MarketScreener Ratings - RaySearch Laboratories AB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
202.80SEK
Average target price
297.50SEK
Spread / Average Target
+46.70%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - RaySearch Laboratories AB
  1. Stock Market
  2. Stocks
  3. RAY B Stock